SCHEMBL29964262

SCHEMBL29964262

CC(C)(C)OC(=O)N1CCC(c2ccc(-c3cc(-c4ccc5c(c4)CCNC5=O)c(N)nc3F)cc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.45
P2RY14 Q15391 1/20 0.43
JAK2 O60674 2/20 0.43
JAK3 P52333 2/20 0.43
PTK2 Q05397 2/20 0.43
GPR119 Q8TDV5 6/20 0.42
RET P07949 1/20 0.41
GSK3B P49841 1/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
HTT P42858 1/20 0.40
SYK P43405 1/20 0.39
NAMPT P43490 1/20 0.39
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39
PIM1 P11309 1/20 0.39
PIM2 Q9P1W9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29964643 0.91 P2RY14 (0.42) P2RY14JAK2JAK3PTK2GPR119
SCHEMBL29964604 0.91 MAPK1 (0.45) MAPK1P2RY14JAK2JAK3PTK2
SCHEMBL29964245 0.90 JAK2 (0.43) P2RY14JAK2JAK3PTK2GPR119
SCHEMBL29965015 0.90 CHEK2 (0.47) MAPK1GPR119GSK3BHTTALOX5AP
SCHEMBL29964275 0.88 NAMPT (0.42) MAPK1GPR119GSK3BNAMPTALOX5AP
SCHEMBL29964997 0.88 RET (0.40) MAPK1GPR119RETGSK3BDDB1
SCHEMBL31079292 0.87 GPR119 (0.46) MAPK1GPR119GSK3BALOX5APFEN1
SCHEMBL29964242 0.86 MAPK1 (0.54) MAPK1P2RY14GPR119RETGSK3B
SCHEMBL29964714 0.85 JAK2 (0.39) MAPK1JAK2GPR119GSK3BALOX5AP
SCHEMBL29964361 0.85 JAK2 (0.37) MAPK1JAK2GPR119GSK3BSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 US disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 MAPK1 141/4885P2RY14 1350/4885JAK2 333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.